KEITH A. KATKIN
@keithakatkin
Director
Building Carbylan Therapeutics, Inc. as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Transposon Therapeutics, Inc. was founded in 2019 and has no closure on record.
Named alongside
At Carbylan Therapeutics, Inc.
- ALBERT L. CHADirector
- DAVID M. GRAVETTExecutive Officer
- DAVID M. RENZIExecutive Officer, Director
- DAVID W. CLAPPERDirector
- EDWARD W. UNKARTDirector
- GUY P. NOHRADirector
- HAYLEY M. LEWISExecutive Officer
- MARCEE M. MARONEYExecutive Officer
- Allan KirkDirector
- Bryan SmithExecutive Officer
- Catherine TurkelExecutive Officer
- Cheryl CohenDirector
- David-Alexandre GrosExecutive Officer, Director
- Erez ChimovitsDirector
- Gary A. LyonsDirector
- Gary LyonsDirector
At Transposon Therapeutics, Inc.
- Brent AhrensDirector
- Brent R. AhrensDirector
- Brian Taylor Slingsby, MD, PHD, MPHDirector
- Daniel R. Hetu, MD, MBADirector
- Dennis PodlesakDirector
- Dennis Taylor PodlesakDirector
- Eckard R. Weber, MDExecutive Officer, Director
- Eckard Weber, M.D.Executive Officer, Director
Contribution
KEITH's ideas, decisions and failures appear here once this profile is claimed.
Companies
- Carbylan Therapeutics, Inc.Pharmaceutical Preparations; formerly Carbylan Therapeutics, Inc.; filing with the SEC since 2005Director · Pharmaceutical Preparations · PALO ALTO, United States
- Transposon Therapeutics, Inc.Director · Pharmaceuticals · WESTPORT, United States · Founded 2019
- Novus Therapeutics, Inc.Pharmaceutical Preparations; listed on Nasdaq as ELDN; filing with the SEC since 2007Director · Pharmaceuticals · Irvine, United States